347 related articles for article (PubMed ID: 15764213)
1. Fifty years of multicentric Castleman's disease.
Waterston A; Bower M
Acta Oncol; 2004; 43(8):698-704. PubMed ID: 15764213
[TBL] [Abstract][Full Text] [Related]
2. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system.
Lopez M; Kainthla R; Lazarte S; Chen W; Nijhawan AE; Knights S
Eur J Haematol; 2024 May; 112(5):723-730. PubMed ID: 38155405
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
5. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
[TBL] [Abstract][Full Text] [Related]
6. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
7. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
8. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
9. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
[TBL] [Abstract][Full Text] [Related]
10. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.
Powles T; Stebbing J; Bazeos A; Hatzimichael E; Mandalia S; Nelson M; Gazzard B; Bower M
Ann Oncol; 2009 Apr; 20(4):775-9. PubMed ID: 19179554
[TBL] [Abstract][Full Text] [Related]
11. Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease.
Boivin G; Côté S; Cloutier N; Abed Y; Maguigad M; Routy JP
J Med Virol; 2002 Nov; 68(3):399-403. PubMed ID: 12226828
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.
Bollen J; Polstra A; Van Der Kuyl A; Weel J; Noorduyn L; Van Oers M; Cornelissen M
BMC Blood Disord; 2003 Dec; 3(1):3. PubMed ID: 14670091
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease.
Brousset P; Cesarman E; Meggetto F; Lamant L; Delsol G
Hum Pathol; 2001 Jan; 32(1):95-100. PubMed ID: 11172301
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.
Soulier J; Grollet L; Oksenhendler E; Cacoub P; Cazals-Hatem D; Babinet P; d'Agay MF; Clauvel JP; Raphael M; Degos L
Blood; 1995 Aug; 86(4):1276-80. PubMed ID: 7632932
[TBL] [Abstract][Full Text] [Related]
15. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Staskus KA; Sun R; Miller G; Racz P; Jaslowski A; Metroka C; Brett-Smith H; Haase AT
J Virol; 1999 May; 73(5):4181-7. PubMed ID: 10196314
[TBL] [Abstract][Full Text] [Related]
16. Frequent detection of Kaposi's sarcoma herpesvirus in germinal centre macrophages from AIDS-related multicentric Castleman's disease.
Valmary S; Richard P; Brousset P
AIDS; 2005 Jul; 19(11):1229-31. PubMed ID: 15990578
[TBL] [Abstract][Full Text] [Related]
17. Genetic Analyses of Contributions of Viral Interleukin-6 Interactions and Signaling to Human Herpesvirus 8 Productive Replication.
Li Q; Xiang Q; Chen D; Nicholas J
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669340
[TBL] [Abstract][Full Text] [Related]
18. Linking KSHV to human cancer.
Wong EL; Damania B
Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195
[TBL] [Abstract][Full Text] [Related]
19. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
[TBL] [Abstract][Full Text] [Related]
20. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.
Ortega L; Cooper CJ; Otoukesh S; Mojtahedzadeh M; Didia CS; Torabi A; Nahleh Z
Rare Tumors; 2014 Jul; 6(3):5480. PubMed ID: 25276327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
